Correction: Oncology Venture today publishes a supplement to the prospectus published April 5, 2019 - without MAR plate Correction: MAR plate removed from this press releaseFor media inquiries Thomas Pedersen, Carrotize PR & Communications E-mail: Telephone +45 60 62 93 90The current OV product por...... 09:32 GMT Thursday 11th April 2019
Oncology Venture today publishes a supplement to the prospectus published April 5, 2019 For media inquiries Thomas Pedersen, Carrotize PR & Communications E-mail: Telephone +45 60 62 93 90The current OV product portfolio includes: LiPlaCis, a liposomal formulation of...... 20:54 GMT Wednesday 10th April 2019
Laboratory set up in Berlin and strategic collaboration with leading German and Danish cancer coorporative groups entered to develop precision medicine for women’s cancers The aim of the collaboration is to further accelerate inclusion of patients into ongoing and future clinical trials of Oncology Venture’s six precision medicine projects. Patient...... 07:30 GMT Friday 29th March 2019
Correction: Removal of the MAR plate in the release: The observation status of Oncology Venture is removed On the 21 of March 2019 Oncology received observation status with reference to material adverse uncertainty in respect of the company’s financial position. With reference to the...... 16:24 GMT Friday 22nd March 2019
The observation status of Oncology Venture is removed On the 21 of March 2019 Oncology received observation status with reference to material adverse uncertainty in respect of the company’s financial position. With reference to the...... 14:43 GMT Friday 22nd March 2019
Oncology Venture has established bridge loan facility On March 20, the company published its Annual Report for 2018 with information on its financial situation. The current rules of First North state that a listed company can be given...... 07:51 GMT Friday 22nd March 2019
NOTICE TO CONVENE ORDINARY GENERAL MEETING Der indkaldes herved til ordinær generalforsamling i Oncology Venture A/S (““):4. april 2019, kl. 16.00 Generalforsamlingen afholdes på adressen: Dagsordenen for generalfor...... 21:11 GMT Wednesday 20th March 2019
Oncology Venture publishes the Annual Report for 2018 We have six drug candidates in our pipeline that together with DRP have the potential to substantially improve the treatments in several cancer indications. LiPlaCis is most advanc...... 16:48 GMT Wednesday 20th March 2019
Oncology Venture receives guarantees and undertakings for a proposed rights issue Considering the positive development of Oncology Venture (“OV” or the “Company”), the Board of Directors has concluded that it is favorable for the existing shareholders to...... 10:05 GMT Friday 15th March 2019
Oncology Venture rearranges its financing agreement with EHGOS (Alpha Blue Ocean) The , based on the issuance of convertible notes and warrants, allows Oncology Venture to receive up to SEK 200 million distributed over twenty (20) tranches during a period of twe...... 12:28 GMT Wednesday 13th March 2019
SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.